IL17A and neoplasm: This suggests that IL-17A may inhibit the occurrence and development of LUAD by suppressing the oxidative stress and inflammatory responses involving Ferulic acid 4-sulfate-related genes and by affecting the extracellular matrix and cell junctions, thereby reshaping the tumor microenvironment.